Vanderbilt researchers on guanfacine for hyperadrenergic patients, Pamela  Roff, B.S. posted on the topic

Vanderbilt researchers on guanfacine for hyperadrenergic patients, Pamela Roff, B.S. posted on the topic

4.6
(271)
Write Review
More
$ 23.99
Add to Cart
In stock
Description

Vanderbilt researchers recently presented new data on the use of guanfacine in 47 hyperadrenergic #POTS patients. They note that 72% of patients responded well…

Brian Robert Tees, MBA on LinkedIn: Transplant Genomics is taking the mission to Capitol Hill! This week, key…

Brian Robert Tees, MBA on LinkedIn: Transplant Genomics is taking the mission to Capitol Hill! This week, key…

Pamela Roff, B.S. on LinkedIn: What is POTS?

Pamela Roff, B.S. on LinkedIn: Vagus Nerve Dysfunction in the Post-COVID-19 Condition

Pamela Roff, B.S. on LinkedIn: Vagus Nerve Dysfunction in the Post-COVID-19 Condition

Brian Robert Tees, MBA on LinkedIn: Transplant Genomics is taking the mission to Capitol Hill! This week, key…

Vanderbilt researchers on guanfacine for hyperadrenergic patients, Pamela Roff, B.S. posted on the topic

Pamela Roff, B.S. on LinkedIn: CALLING ALL RESEARCHERS! Dysautonomia International is now accepting grant…

Pamela Roff, B.S. on LinkedIn: I'm excited to announce that I've accepted a new position as Provider…

Silvia De Rosa on LinkedIn: Acute Kidney Injury (AKI) and Blood Purification Therapy Survey

Silvia De Rosa on LinkedIn: Acute Kidney Injury (AKI) and Blood Purification Therapy Survey

Pamela Roff, B.S. - Provider Relations - South Denver Cardiology Associates

Silvia De Rosa on LinkedIn: Acute Kidney Injury (AKI) and Blood Purification Therapy Survey